A new study published in February 2020 in the journal JAMA Otolaryngology-Head and Neck Surgery shows that using mainstream media to depict rare diseases in a realistic manner can prompt greater public awareness and support for such conditions.
Read More

Researchers from the Massachusetts Institute of Technology (MIT) have made a scientific breakthrough where their machine-learning algorithm or Artificial Intelligence (AI) program successfully created a novel antibiotic compound. The drug has since then been tested on deadly bacteria in the lab, and in lab mice with a considerable amount of success, explain the researchers. The study results appear in the latest issue of the journal Cell.
Read More

Viruses are parasites. The only way they can grow is by hijacking their hosts. When they infect a human host, viruses use human proteins to multiply and modify the human cells to sustain the infection. At the same time, the human host activates defense mechanisms to fight the infection.
Read More

New research confirms that the lower 0.25 mg/kg dose of the clot-busting agent tenecteplase is appropriate for eligible stroke patients and can reduce the need for mechanical clot removal, according to late breaking science presented today at the American Stroke Association’s International Stroke Conference 2020.
Read More

About 8 percent of West Virginia newborns are exposed to alcohol two to four weeks before birth, according to a new study.
Read More

The University of Tennessee System has announced the creation of the UT One Health Initiative, an effort to enhance research collaborations across the state and region to address rapidly emerging health challenges.
Read More

When a newborn suffers lack of oxygen before or during birth, doctors have very little time to save precious brain tissue.
Read More

There has been some debate on whether or not to pile up on calories at the first meal of the day. According to German researchers, to lose weight, one must eat a healthy and hearty breakfast.
Read More

Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus, 2019-nCoV.
Read More

An experimental drug already shown to be safe and help some patients with clear cell renal cell carcinoma, a deadly form of kidney cancer, effectively disables its molecular target.
Read More